Mednax Inc (MD)
Cash ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 229,940 | 103,831 | 19,402 | 7,998 | 73,258 | 21,179 | 5,849 | 6,124 | 9,824 | 8,668 | 14,088 | 7,179 | 387,391 | 357,914 | 338,157 | 269,630 | 1,123,840 | 294,512 | 132,151 | 312,155 |
| Short-term investments | US$ in thousands | 118,566 | 116,621 | 113,795 | 107,473 | 104,485 | 103,541 | 98,490 | 96,709 | 93,239 | 91,396 | 93,386 | 89,576 | 99,715 | 98,510 | 100,763 | 100,811 | 104,870 | 81,574 | 90,642 | 85,041 |
| Total current liabilities | US$ in thousands | 434,110 | 373,080 | 310,156 | 207,035 | 388,946 | 350,444 | 320,318 | 226,675 | 374,225 | 351,694 | 287,463 | 269,727 | 394,118 | 397,564 | 351,105 | 326,958 | 423,157 | 488,364 | 383,933 | 346,400 |
| Cash ratio | 0.80 | 0.59 | 0.43 | 0.56 | 0.46 | 0.36 | 0.33 | 0.45 | 0.28 | 0.28 | 0.37 | 0.36 | 1.24 | 1.15 | 1.25 | 1.13 | 2.90 | 0.77 | 0.58 | 1.15 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($229,940K
+ $118,566K)
÷ $434,110K
= 0.80
The cash ratio of Mednax Inc has been fluctuating over the years based on the provided data. The cash ratio represents the company's ability to cover its short-term liabilities using its cash and cash equivalents.
From March 31, 2020 to December 31, 2021, the cash ratio ranged between 0.58 and 2.90, indicating some variability in the company's liquidity position during this period. The highest cash ratio of 2.90 as of December 31, 2020, suggests that the company had a strong ability to cover its short-term obligations with its available cash.
However, in the following quarters, the cash ratio decreased, hovering around 1.00 from March 31, 2021 to March 31, 2024. This suggests a potential decrease in the company's ability to cover its short-term liabilities with its cash reserves.
The cash ratio dropped to as low as 0.28 on September 30, 2022, indicating a lower level of liquidity at that point in time. Although there were some fluctuations, the company's cash ratio generally stayed around 1 during the period from March 31, 2021 to March 31, 2024.
Overall, a cash ratio of less than 1 means that the company may have difficulty meeting its short-term obligations solely with its available cash. It is important for Mednax Inc to monitor its cash reserves and manage its liquidity effectively to ensure the company can meet its financial obligations in a timely manner.
Peer comparison
Dec 31, 2024